Gene · 6495
Papers2,008
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,008
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Branchio-oto-renal syndrome: a narrative review. | Child Kidney Dis | 2026 | 42779651 | PubTator, text mining | PubMed |
| SIX1 drives acute myeloid leukemia progression by reprogramming glycolytic metabolism and impairing CD8⁺ T-cell effector function. | Immunol Res | 2026 | 42693356 | PubTator, text mining | PubMed |
| Cross-cancer transcriptomic analysis reveals conserved developmental, ferroptosis, and immune remodeling modules in Wilms tumor and oral cancer. | Front Genet | 2026 | 42670482 | PubTator, text mining | PubMed |
| The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer. | Cancer Lett | 2026 | 42601012 | PubTator, text mining | PubMed |
| Glycolytic reprogramming and the EMT drive cervical cancer progression via the NQO1/HIF1α-SIX1 axis. | iScience | 2026 | 42571403 | PubTator, text mining | PubMed |
| SIX1 is required for adult cochlear sensory epithelium homeostasis and auditory function. | Proc Natl Acad Sci U S A | 2026 | 42546190 | PubTator, text mining | PubMed |
| GRP78 Drives NSCLC Stemness and EMT via a SIX1/β-Catenin Signaling Axis. | Drug Dev Res | 2026 | 42546137 | PubTator, text mining | PubMed |
| Context-dependent regulation of SIX1 by ETS1 within EMT-associated transcriptional networks. | Turk J Biol | 2026 | 42500691 | PubTator, text mining | PubMed |
| Direct and indirect regulation of SIX1+EYA transcriptional activity by PA2G4, MCRS1, and SOBP. | Tissue Cell | 2026 | 42475796 | PubTator, text mining | PubMed |
| Genetic Diagnosis of Non-Syndromic Hearing Loss in South Indian Consanguineous Families Using Whole-Exome Sequencing. | Medicina (Kaunas) | 2026 | 42356053 | PubTator, text mining | PubMed |
| Senescence-circadian interplay stratifies patient prognosis and reveals immune remodeling heterogeneity in colorectal cancer. | Front Immunol | 2026 | 42317343 | PubTator, text mining | PubMed |
| SIX1 branchio-oto-renal syndrome variants have different effects on embryonic craniofacial gene expression and cartilage formation. | Development | 2026 | 42290293 | PubTator, text mining | PubMed |
| Investigating the Population Dynamics of Fusarium oxysporum f. sp. eustomae Causing Stem Rot in Lisianthus with the PCR-Based Markers and Virulence. | Plant Dis | 2026 | 42263061 | PubTator, text mining | PubMed |
| Prognostic significance of IDH1 promoter methylation and associated genome-wide alterations in breast cancer. | Sci Rep | 2026 | 42204197 | PubTator, text mining | PubMed |
| Nanoparticles-mediated dual metabolic-immunological intervention reverses immunosuppression in muscle invasive bladder cancer. | Biomaterials | 2026 | 42190515 | PubTator, text mining | PubMed |
| SIX1 mediates pulmonary arterial hypertension endothelial dysfunction through the IL-6/STAT3 axis. | J Thorac Dis | 2026 | 42182661 | PubTator, text mining | PubMed |
| Systematic Review: Prognostic Molecular Biomarkers in Wilms Tumors. | JCO Precis Oncol | 2026 | 42150146 | PubTator, text mining | PubMed |
| Gene expression and histological assessment of capsular fibrosis in post-traumatic shoulder stiffness following plate fixation of proximal humeral fractures: an exploratory pilot study. | BMC Musculoskelet Disord | 2026 | 42104357 | PubTator, text mining | PubMed |
| Correction to "Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells". | Adv Sci (Weinh) | 2026 | 41961072 | PubTator, text mining | PubMed |
| An Intermediate Mesoderm Premyogenic Niche Supports Early Human Myogenic Lineage Progression. | bioRxiv | 2026 | 41958983 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6495/papers